Brands and entrepreneurs in the supplements segment in 2026 face a clear strategic decision: build their own brand via white label (private label) or distribute via B2B2C platform with a network of professionals. The choice has profound implications for capital, time and risk. This comparison provides the essentials for an informed decision.

The essential distinction

Direct answer: White label is a model in which the company develops its own formulation (or outsources development), produces via contracted manufacturer, packages with its own visual identity, registers with regulatory bodies and distributes through its own channels. B2B2C is a model in which the existing brand (yours or a third party) uses a platform that connects to the professional channel to distribute via curation by physical educators. Investment, horizon, margin and risk are significantly different in the two. The choice depends on the company’s stage, available capital and strategic vision.

Profile of each model

White label (private label)

Who operates: entrepreneur/company that wants to build its own brand with total control.

Typical chain:

  1. Portfolio definition
  2. Formulation development (own laboratory or third party)
  3. Hiring a third-party manufacturer
  4. Packaging design and visual identity
  5. Regulatory registration (MAPA/ANVISA)
  6. Minimum production batch (often R$100-500k)
  7. Distribution (retail, own e-commerce, marketplaces, B2B)
  8. Brand Marketing

Typical initial investment: R$300k-2M for serious entry.

Horizon for ROI: 18-36 months.

Typical gross margin: 40-60% after COGS (product cost).

B2B2C

Who operates: existing brand (or individual professional) who wants to accelerate qualified distribution.

Typical chain:

  1. Existing brand with validated and regularized product
  2. Onboarding on a B2B2C platform
  3. Technical material to support the channel
  4. Activation of a professional network
  5. Operation (orders, logistics via the platform)
  6. Channel management

Typical initial investment: R$20-100k (ready product + material + onboarding).

Horizon for ROI: 6-18 months.

Typical gross margin: 15-25% after professional + platform commissions.

Comparison table

DimensionWhite labelB2B2C
Initial investmentHigh (R$ 300k+)Medium (R$ 20-100k)
Time to ROI18-36 meses6-18 meses
Margin per sale40-60% bruta15-25% após comissões
Control over productTotalPartial (depends on brand)
Regulatory riskAll yoursShared
ScalabilityDepends on operationDischarge via network
Brand asset buildingVery highAverage
Channel dependencyLow (various channels)High (chosen platform)
Market learning speedLowHigh

When white labeling makes more sense

Favorable contexts

  • Sufficient capital for 24 months of operation
  • Long term vision (5-10 years) of building brand
  • Clear technical differentiator (proprietary formulation, special origin)
  • Complete team (regulatory, marketing, operations, sales)
  • Long Time Acceptance for ROI

Main risks

  • Stranded stock if demand does not materialize
  • Competition with established brands in the same space
  • Capital locked in operation that takes time to return
  • Own regulatory problem

When B2B2C makes more sense

Favorable contexts

  • Brand in consolidation wanting to accelerate
  • Limited capital but validated product
  • Learning speed matters (knowing quickly if the market accepts it)
  • Lean team
  • Focus on relationship with professional channel

Main risks

  • Dependency on chosen platform
  • Commissions reducing unit margin
  • Lower brand visibility directly to end consumers
  • Need for constant alignment with professionals

Hybrid strategy: the two together

Some mature players operate both models simultaneously:

White label: own product distributed in physical retail, own e-commerce, marketplaces.

B2B2C: the same product (or complementary line) distributed via a network of professionals.

Advantages of the combination

  • Coverage of different channels (general consumer + qualified professional audience)
  • Risk diversification
  • Cash velocity (B2B2C feeds the short term) + brand building (white feeds the long term)

Challenges

  • Coherence between channels (price, positioning, narrative)
  • Inventory management for two channels
  • Possible cannibalization if not well structured

Hybrid strategy usually makes sense from the 2nd-3rd year of operation, after consolidation in one of the models.

Decisions at each stage

Year 0-1: which one to start

  • Capital < R$100k: B2B2C almost always
  • Capital R$100k-500k: B2B2C + preparation for white label
  • Capital > R$500k: white label is viable if you have a vision and team

Year 1-2: Expand

  • White label: expand line, enter new channels
  • B2B2C: increase professional network, add SKUs

Year 2-3: combine (if it makes sense)

  • Already consolidated white brand can enter B2B2C
  • B2B2C brand with stable revenue can create its own (white) line

Tracking metrics

For white label

  • Inventory turnover
  • Gross margin by SKU
  • Customer acquisition cost in the direct channel
  • Buyback
  • Retail market share

For B2B2C

  • Number of active professionals
  • Sell-through
  • Average ticket
  • End customer LTV
  • Commission paid vs net revenue

Common mistakes

White brand with insufficient capital. Locking up R$200k waiting 24 months breaks the bank.

B2B2C without real quality product. Platform can deliver channel, but bad product burns out quickly.

Compare unit margin separately. High margin on a white label can come with a high CAC; Lower margin in B2B2C can come with high volume.

Getting into B2B2C thinking it’s easy. Requires alignment with the channel, technical material, relationship management.

Forcing white label when B2B2C would comply. Disproportionate investment for the phase.

Ignoring white label regulations. Mistakes can be costly and time-consuming.

Key Takeaway Points

  • White label builds brand asset; B2B2C accelerates distribution
  • Initial investment and ROI horizon are very different
  • Margin per sale vs total margin in volume have different readings
  • Hybrid strategy is viable in the maturity phase
  • Choice depends on capital, vision and phase — there is no universal “best”

Additional reading:


Mega Suplementos delivers B2B2C infrastructure for brands that want to accelerate qualified distribution, with or without parallel white label operations. Talk to the team.